{
    "abstract": "Infection with Leishmania parasites results in a range of clinical manifestations and outcomes, the most severe of which is visceral leishmaniasis (VL). Vaccination will likely provide the most effective long-term control strategy, as the large number of vectors and potential infectious reservoirs renders sustained interruption of Leishmania parasite transmission extremely difficult. Selection of the best vaccine is complicated because, although several vaccine antigen candidates have been proposed, they have emerged following production in different platforms. To consolidate the information that has been generated into a single vaccine platform, we expressed seven candidates as recombinant proteins in E. coli. After verifying that each recombinant protein could be recognized by VL patients, we evaluated their protective efficacy against experimental L. donovani infection of mice. Administration in formulation with the Th1-potentiating adjuvant GLA-SE indicated that each antigen could elicit antigen-specific Th1 responses that were protective. Considering the ability to reduce parasite burden along with additional factors such as sequence identity across Leishmania species, we then generated a chimeric fusion protein comprising a combination of the 8E, p21 and SMT proteins. This E. coli -expressed fusion protein was also demonstrated to protect against L. donovani infection. These data indicate a novel recombinant vaccine antigen with the potential for use in VL control programs.",
    "bib_entries": {
        "bib0165": null,
        "bib0170": {
            "authors": [
                {
                    "first": "Filipe",
                    "initial": "F.",
                    "last": "Dantas-Torres"
                },
                {
                    "first": "Domenico",
                    "initial": "D.",
                    "last": "Otranto"
                }
            ],
            "doi": "10.1016/j.pt.2015.09.004",
            "firstpage": "43",
            "issn": "14714922",
            "lastpage": "55",
            "pmid": "26507152",
            "pub_year": 2016,
            "title": "Best Practices for Preventing Vector-Borne Diseases in Dogs and Humans",
            "volume": "32"
        },
        "bib0175": {
            "authors": [
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Sundar"
                },
                {
                    "first": "G.",
                    "initial": "G.",
                    "last": "Agrawal"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Rai"
                },
                {
                    "first": "M. K.",
                    "initial": "M.K.",
                    "last": "Makharia"
                },
                {
                    "first": "H. W.",
                    "initial": "H.W.",
                    "last": "Murray"
                }
            ],
            "firstpage": "419",
            "issn": "09598146",
            "lastpage": "422",
            "pmid": "11520836",
            "pub_year": 2001,
            "title": "Treatment of Indian visceral leishmaniasis with single or daily infusions of low dose liposomal amphotericin B: Randomised trial",
            "volume": "323"
        },
        "bib0180": {
            "authors": [
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Sundar"
                },
                {
                    "first": "T. K.",
                    "initial": "T.K.",
                    "last": "Jha"
                },
                {
                    "first": "C. P.",
                    "initial": "C.P.",
                    "last": "Thakur"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Mishra"
                },
                {
                    "first": "V. P.",
                    "initial": "V.P.",
                    "last": "Singh"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Buffels"
                }
            ],
            "doi": "10.4269/ajtmh.2002.66.143",
            "firstpage": "143",
            "issn": "00029637",
            "lastpage": "146",
            "pmid": "12135284",
            "pub_year": 2002,
            "title": "Low-dose liposomal amphotericin B in refractory Indian visceral leishmaniasis: A multicenter study",
            "volume": "66"
        },
        "bib0185": {
            "authors": [
                {
                    "first": "Shyam",
                    "initial": "S.",
                    "last": "Sundar"
                },
                {
                    "first": "Himanshu",
                    "initial": "H.",
                    "last": "Mehta"
                },
                {
                    "first": "A. V.",
                    "initial": "A.V.",
                    "last": "Suresh"
                },
                {
                    "first": "Shri P.",
                    "initial": "S.P.",
                    "last": "Singh"
                },
                {
                    "first": "Madhukar",
                    "initial": "M.",
                    "last": "Rai"
                },
                {
                    "first": "Henry W.",
                    "initial": "H.W.",
                    "last": "Murray"
                }
            ],
            "doi": "10.1086/380971",
            "firstpage": "377",
            "issn": "10584838",
            "lastpage": "383",
            "pmid": "14727208",
            "pub_year": 2004,
            "title": "Amphotericin B Treatment for Indian Visceral Leishmaniasis: Conventional versus Lipid Formulations",
            "volume": "38"
        },
        "bib0190": {
            "authors": [
                {
                    "first": "Greg",
                    "initial": "G.",
                    "last": "Matlashewski"
                },
                {
                    "first": "Byron",
                    "initial": "B.",
                    "last": "Arana"
                },
                {
                    "first": "Axel",
                    "initial": "A.",
                    "last": "Kroeger"
                },
                {
                    "first": "Sujit",
                    "initial": "S.",
                    "last": "Battacharya"
                },
                {
                    "first": "Shyam",
                    "initial": "S.",
                    "last": "Sundar"
                },
                {
                    "first": "Pradeep",
                    "initial": "P.",
                    "last": "Das"
                },
                {
                    "first": "Prabhat Kumar",
                    "initial": "P.K.",
                    "last": "Sinha"
                },
                {
                    "first": "Suman",
                    "initial": "S.",
                    "last": "Rijal"
                },
                {
                    "first": "Dinesh",
                    "initial": "D.",
                    "last": "Mondal"
                },
                {
                    "first": "Dan",
                    "initial": "D.",
                    "last": "Zilberstein"
                },
                {
                    "first": "Jorge",
                    "initial": "J.",
                    "last": "Alvar"
                }
            ],
            "doi": "10.1016/S1473-3099(10)70320-0",
            "firstpage": "322",
            "issn": "14733099",
            "lastpage": "325",
            "pmid": "21453873",
            "pub_year": 2011,
            "title": "Visceral leishmaniasis: Elimination with existing interventions",
            "volume": "11"
        },
        "bib0195": {
            "authors": [
                {
                    "first": "Shyam",
                    "initial": "S.",
                    "last": "Sundar"
                },
                {
                    "first": "Jaya",
                    "initial": "J.",
                    "last": "Chakravarty"
                }
            ],
            "doi": "10.3390/ijerph7124267",
            "firstpage": "4267",
            "issn": "16604601",
            "lastpage": "4277",
            "pmid": "21318007",
            "pub_year": 2010,
            "title": "Antimony toxicity",
            "volume": "7"
        },
        "bib0200": {
            "authors": [
                {
                    "first": "Shyam",
                    "initial": "S.",
                    "last": "Sundar"
                },
                {
                    "first": "Jaya",
                    "initial": "J.",
                    "last": "Chakravarty"
                },
                {
                    "first": "Dipti",
                    "initial": "D.",
                    "last": "Agarwal"
                },
                {
                    "first": "Madhukar",
                    "initial": "M.",
                    "last": "Rai"
                },
                {
                    "first": "Henry W.",
                    "initial": "H.W.",
                    "last": "Murray"
                }
            ],
            "doi": "10.1056/NEJMoa0903627",
            "firstpage": "504",
            "issn": "00284793",
            "lastpage": "512",
            "pub_year": 2010,
            "title": "Single-dose liposomal amphotericin B for visceral leishmaniasis in India",
            "volume": "362"
        },
        "bib0205": {
            "authors": [
                {
                    "first": "Shyam",
                    "initial": "S.",
                    "last": "Sundar"
                },
                {
                    "first": "Prabhat Kumar",
                    "initial": "P.K.",
                    "last": "Sinha"
                },
                {
                    "first": "Deepak K.",
                    "initial": "D.K.",
                    "last": "Verma"
                },
                {
                    "first": "Nawin",
                    "initial": "N.",
                    "last": "Kumar"
                },
                {
                    "first": "Shahnawaj",
                    "initial": "S.",
                    "last": "Alam"
                },
                {
                    "first": "Krishna",
                    "initial": "K.",
                    "last": "Pandey"
                },
                {
                    "first": "Poonam",
                    "initial": "P.",
                    "last": "Kumari"
                },
                {
                    "first": "Vidyanand",
                    "initial": "V.",
                    "last": "Ravidas"
                },
                {
                    "first": "Jaya",
                    "initial": "J.",
                    "last": "Chakravarty"
                },
                {
                    "first": "Neena",
                    "initial": "N.",
                    "last": "Verma"
                },
                {
                    "first": "Jonathan",
                    "initial": "J.",
                    "last": "Berman"
                },
                {
                    "first": "Hashim",
                    "initial": "H.",
                    "last": "Ghalib"
                },
                {
                    "first": "Byron",
                    "initial": "B.",
                    "last": "Arana"
                }
            ],
            "doi": "10.1016/j.trstmh.2010.10.008",
            "firstpage": "115",
            "issn": "00359203",
            "lastpage": "117",
            "pmid": "21129762",
            "pub_year": 2011,
            "title": "Ambisome plus miltefosine for Indian patients with kala-azar",
            "volume": "105"
        },
        "bib0210": {
            "authors": [
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Badaro"
                },
                {
                    "first": "I.",
                    "initial": "I.",
                    "last": "Lobo"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Nakatani"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Mui\u00f1os"
                },
                {
                    "first": "E. M.",
                    "initial": "E.M.",
                    "last": "Netto"
                },
                {
                    "first": "R. N.",
                    "initial": "R.N.",
                    "last": "Coler"
                },
                {
                    "first": "S. G.",
                    "initial": "S.G.",
                    "last": "Reed"
                }
            ],
            "doi": "10.1590/S1413-86702001000400008",
            "firstpage": "223",
            "issn": "14138670",
            "lastpage": "232",
            "pmid": "11712967",
            "pub_year": 2001,
            "title": "Successful use of a defined antigen/GM-CSF adjuvant vaccine to treat mucosal Leishmaniasis refractory to antimony: A case report.",
            "volume": "5"
        },
        "bib0215": {
            "authors": [
                {
                    "first": "Sassan",
                    "initial": "S.",
                    "last": "Noazin"
                },
                {
                    "first": "Ali",
                    "initial": "A.",
                    "last": "Khamesipour"
                },
                {
                    "first": "Lawrence H.",
                    "initial": "L.H.",
                    "last": "Moulton"
                },
                {
                    "first": "Marcel",
                    "initial": "M.",
                    "last": "Tanner"
                },
                {
                    "first": "Kiumarss",
                    "initial": "K.",
                    "last": "Nasseri"
                },
                {
                    "first": "Farrokh",
                    "initial": "F.",
                    "last": "Modabber"
                },
                {
                    "first": "Iraj",
                    "initial": "I.",
                    "last": "Sharifi"
                },
                {
                    "first": "E. A.G.",
                    "initial": "E.A.G.",
                    "last": "Khalil"
                },
                {
                    "first": "Ivan Dario Velez",
                    "initial": "I.D.V.",
                    "last": "Bernal"
                },
                {
                    "first": "Carlos M.F.",
                    "initial": "C.M.F.",
                    "last": "Antunes"
                },
                {
                    "first": "Peter G.",
                    "initial": "P.G.",
                    "last": "Smith"
                }
            ],
            "doi": "10.1016/j.vaccine.2009.05.084",
            "firstpage": "4747",
            "issn": "0264410X",
            "lastpage": "4753",
            "pmid": "19540273",
            "pub_year": 2009,
            "title": "Efficacy of killed whole-parasite vaccines in the prevention of leishmaniasis-A meta-analysis",
            "volume": "27"
        },
        "bib0220": {
            "authors": [
                {
                    "first": "Odair",
                    "initial": "O.",
                    "last": "Genaro"
                },
                {
                    "first": "Vicente Paulo Coelho Peixoto",
                    "initial": "V.P.C.P.",
                    "last": "De Toledo"
                },
                {
                    "first": "Carlos Alberto",
                    "initial": "C.A.",
                    "last": "Da Costa"
                },
                {
                    "first": "Marco Victor",
                    "initial": "M.V.",
                    "last": "Hermeto"
                },
                {
                    "first": "Luis Carlos Crocco",
                    "initial": "L.C.C.",
                    "last": "Afonso"
                },
                {
                    "first": "Wilson",
                    "initial": "W.",
                    "last": "Mayrink"
                }
            ],
            "doi": "10.1016/0738-081X(96)00040-5",
            "firstpage": "503",
            "issn": "0738081X",
            "lastpage": "512",
            "pmid": "8889328",
            "pub_year": 1996,
            "title": "Vaccine for prophylaxis and immunotherapy, Brazil",
            "volume": "14"
        },
        "bib0225": {
            "authors": [
                {
                    "first": "Mehdi",
                    "initial": "M.",
                    "last": "Mohebali"
                },
                {
                    "first": "Ali",
                    "initial": "A.",
                    "last": "Khamesipour"
                },
                {
                    "first": "Iraj",
                    "initial": "I.",
                    "last": "Mobedi"
                },
                {
                    "first": "Zabih",
                    "initial": "Z.",
                    "last": "Zarei"
                },
                {
                    "first": "Reza",
                    "initial": "R.",
                    "last": "Hashemi-Fesharki"
                }
            ],
            "doi": "10.1016/j.vaccine.2004.03.058",
            "firstpage": "4097",
            "issn": "0264410X",
            "lastpage": "4100",
            "pmid": "15364462",
            "pub_year": 2004,
            "title": "Double-blind randomized efficacy field trial of alum precipitated autoclaved Leishmania major vaccine mixed with BCG against canine visceral leishmaniasis in Meshkin-Shahr district, I.R. Iran",
            "volume": "22"
        },
        "bib0230": {
            "authors": [
                {
                    "first": "Malcolm S.",
                    "initial": "M.S.",
                    "last": "Duthie"
                },
                {
                    "first": "Steven G.",
                    "initial": "S.G.",
                    "last": "Reed"
                }
            ],
            "doi": "10.1007/s40475-014-0024-9",
            "firstpage": "154",
            "issn": "21963045",
            "lastpage": "162",
            "pub_year": 2014,
            "title": "The Emergence of Defined Subunit Vaccines for the Prevention of Leishmaniasis",
            "volume": "1"
        },
        "bib0235": {
            "authors": [
                {
                    "first": "Rajan",
                    "initial": "R.",
                    "last": "Guha"
                },
                {
                    "first": "Shantanabha",
                    "initial": "S.",
                    "last": "Das"
                },
                {
                    "first": "June",
                    "initial": "J.",
                    "last": "Ghosh"
                },
                {
                    "first": "Kshudiram",
                    "initial": "K.",
                    "last": "Naskar"
                },
                {
                    "first": "Ashok",
                    "initial": "A.",
                    "last": "Mandala"
                },
                {
                    "first": "Shyam",
                    "initial": "S.",
                    "last": "Sundar"
                },
                {
                    "first": "Jean Claude",
                    "initial": "J.C.",
                    "last": "Dujardin"
                },
                {
                    "first": "Syamal",
                    "initial": "S.",
                    "last": "Roy"
                }
            ],
            "doi": "10.1016/j.vaccine.2013.02.025",
            "firstpage": "1905",
            "issn": "0264410X",
            "lastpage": "1915",
            "pmid": "23499564",
            "pub_year": 2013,
            "title": "Heterologous priming-boosting with DNA and vaccinia virus expressing kinetoplastid membrane protein-11 induces potent cellular immune response and confers protection against infection with antimony resistant and sensitive strains of Leishmania (Leishmania) donovani",
            "volume": "31"
        },
        "bib0240": {
            "authors": [
                {
                    "first": "Poonam",
                    "initial": "P.",
                    "last": "Tewary"
                },
                {
                    "first": "Manju",
                    "initial": "M.",
                    "last": "Jain"
                },
                {
                    "first": "Mayurbhai H.",
                    "initial": "M.H.",
                    "last": "Sahani"
                },
                {
                    "first": "Shailendra",
                    "initial": "S.",
                    "last": "Saxena"
                },
                {
                    "first": "Rentala",
                    "initial": "R.",
                    "last": "Madhubala"
                }
            ],
            "doi": "10.1086/430348",
            "firstpage": "2130",
            "issn": "00221899",
            "lastpage": "2137",
            "pmid": "15898000",
            "pub_year": 2005,
            "title": "A heterologous prime-boost vaccination regimen using ORFF DNA and recombinant ORFF protein confers protective immunity against experimental visceral Leishmaniasis",
            "volume": "191"
        },
        "bib0245": {
            "authors": [
                {
                    "first": "Anirban",
                    "initial": "A.",
                    "last": "Ghosh"
                },
                {
                    "first": "Wen Wei",
                    "initial": "W.W.",
                    "last": "Zhang"
                },
                {
                    "first": "Greg",
                    "initial": "G.",
                    "last": "Matlashewski"
                }
            ],
            "doi": "10.1016/S0264-410X(01)00322-X",
            "firstpage": "59",
            "issn": "0264410X",
            "lastpage": "66",
            "pmid": "11567746",
            "pub_year": 2001,
            "title": "Immunization with A2 protein results in a mixed Th1/Th2 and a humoral response which protects mice against Leishmania donovani infections",
            "volume": "20"
        },
        "bib0250": {
            "authors": [
                {
                    "first": "Rajan",
                    "initial": "R.",
                    "last": "Guha"
                },
                {
                    "first": "Deepika",
                    "initial": "D.",
                    "last": "Gupta"
                },
                {
                    "first": "Ruchir",
                    "initial": "R.",
                    "last": "Rastogi"
                },
                {
                    "first": "Rajagopal",
                    "initial": "R.",
                    "last": "Vikram"
                },
                {
                    "first": "Ganga",
                    "initial": "G.",
                    "last": "Krishnamurthy"
                },
                {
                    "first": "Sanjiva",
                    "initial": "S.",
                    "last": "Bimal"
                },
                {
                    "first": "Syamal",
                    "initial": "S.",
                    "last": "Roy"
                },
                {
                    "first": "Amitabha",
                    "initial": "A.",
                    "last": "Mukhopadhyay"
                }
            ],
            "doi": "10.1126/scitranslmed.3006406",
            "issn": "19466234",
            "pmid": "24027025",
            "pub_year": 2013,
            "title": "Vaccination with leishmania hemoglobin receptor-encoding DNA protects against visceral leishmaniasis",
            "volume": "5"
        },
        "bib0255": {
            "authors": [
                {
                    "first": "Rhea N.",
                    "initial": "R.N.",
                    "last": "Coler"
                },
                {
                    "first": "Sylvie",
                    "initial": "S.",
                    "last": "Bertholet"
                },
                {
                    "first": "Magdalini",
                    "initial": "M.",
                    "last": "Moutaftsi"
                },
                {
                    "first": "Jeff A.",
                    "initial": "J.A.",
                    "last": "Guderian"
                },
                {
                    "first": "Hillarie Plessner",
                    "initial": "H.P.",
                    "last": "Windish"
                },
                {
                    "first": "Susan L.",
                    "initial": "S.L.",
                    "last": "Baldwin"
                },
                {
                    "first": "Elsa M.",
                    "initial": "E.M.",
                    "last": "Laughlin"
                },
                {
                    "first": "Malcolm S.",
                    "initial": "M.S.",
                    "last": "Duthie"
                },
                {
                    "first": "Christopher B.",
                    "initial": "C.B.",
                    "last": "Fox"
                },
                {
                    "first": "Darrick",
                    "initial": "D.",
                    "last": "Carter"
                },
                {
                    "first": "Martin",
                    "initial": "M.",
                    "last": "Friede"
                },
                {
                    "first": "Thomas S.",
                    "initial": "T.S.",
                    "last": "Vedvick"
                },
                {
                    "first": "Steven G.",
                    "initial": "S.G.",
                    "last": "Reed"
                }
            ],
            "doi": "10.1371/journal.pone.0016333",
            "issn": "19326203",
            "pmid": "21298114",
            "pub_year": 2011,
            "title": "Development and characterization of synthetic glucopyranosyl lipid adjuvant system as a vaccine adjuvant",
            "volume": "6"
        },
        "bib0260": {
            "authors": [
                {
                    "first": "Rhea N.",
                    "initial": "R.N.",
                    "last": "Coler"
                },
                {
                    "first": "Yasir A.W.",
                    "initial": "Y.A.W.",
                    "last": "Skeiky"
                },
                {
                    "first": "Karen",
                    "initial": "K.",
                    "last": "Bernards"
                },
                {
                    "first": "Kay",
                    "initial": "K.",
                    "last": "Greeson"
                },
                {
                    "first": "Darrick",
                    "initial": "D.",
                    "last": "Carter"
                },
                {
                    "first": "Charisa D.",
                    "initial": "C.D.",
                    "last": "Cornellison"
                },
                {
                    "first": "Farrokh",
                    "initial": "F.",
                    "last": "Modabber"
                },
                {
                    "first": "Antonio",
                    "initial": "A.",
                    "last": "Campos-Neto"
                },
                {
                    "first": "Steven G.",
                    "initial": "S.G.",
                    "last": "Reed"
                }
            ],
            "doi": "10.1128/IAI.70.8.4215-4225.2002",
            "firstpage": "4215",
            "issn": "00199567",
            "lastpage": "4225",
            "pmid": "12117930",
            "pub_year": 2002,
            "title": "Immunization with a polyprotein vaccine consisting of the T-cell antigens thiol-specific antioxidant, Leishmania major stress-inducible protein 1, and Leishmania elongation initiation factor protects against leishmaniasis",
            "volume": "70"
        },
        "bib0265": {
            "authors": [
                {
                    "first": "Y. A.W.",
                    "initial": "Y.A.W.",
                    "last": "Skeiky"
                },
                {
                    "first": "D. R.",
                    "initial": "D.R.",
                    "last": "Benson"
                },
                {
                    "first": "J. A.",
                    "initial": "J.A.",
                    "last": "Guderian"
                },
                {
                    "first": "J. A.",
                    "initial": "J.A.",
                    "last": "Whittle"
                },
                {
                    "first": "O.",
                    "initial": "O.",
                    "last": "Bacelar"
                },
                {
                    "first": "E. M.",
                    "initial": "E.M.",
                    "last": "Carvalho"
                },
                {
                    "first": "S. G.",
                    "initial": "S.G.",
                    "last": "Reed"
                }
            ],
            "doi": "10.1128/iai.63.10.4105-4114.1995",
            "firstpage": "4105",
            "issn": "00199567",
            "lastpage": "4114",
            "pmid": "7558326",
            "pub_year": 1995,
            "title": "Immune responses of leishmaniasis patients to heat shock proteins of Leishmania species and humans",
            "volume": "63"
        },
        "bib0270": {
            "authors": [
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Chenik"
                },
                {
                    "first": "H.",
                    "initial": "H.",
                    "last": "Louzir"
                },
                {
                    "first": "H.",
                    "initial": "H.",
                    "last": "Ksontini"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Dilou"
                },
                {
                    "first": "I.",
                    "initial": "I.",
                    "last": "Abdmouleh"
                },
                {
                    "first": "K.",
                    "initial": "K.",
                    "last": "Dellagi"
                }
            ],
            "doi": "10.1016/j.vaccine.2005.12.027",
            "firstpage": "2521",
            "issn": "0264410X",
            "lastpage": "2529",
            "pmid": "16417957",
            "pub_year": 2006,
            "title": "Vaccination with the divergent portion of the protein histone H2B of Leishmania protects susceptible BALB/c mice against a virulent challenge with Leishmania major",
            "volume": "24"
        },
        "bib0275": {
            "authors": [
                {
                    "first": "Reema",
                    "initial": "R.",
                    "last": "Gupta"
                },
                {
                    "first": "Pramod K.",
                    "initial": "P.K.",
                    "last": "Kushawaha"
                },
                {
                    "first": "Chandra Dev Pati",
                    "initial": "C.D.P.",
                    "last": "Tripathi"
                },
                {
                    "first": "Shyam",
                    "initial": "S.",
                    "last": "Sundar"
                },
                {
                    "first": "Anuradha",
                    "initial": "A.",
                    "last": "Dube"
                }
            ],
            "doi": "10.1016/j.ijpara.2012.02.013",
            "firstpage": "429",
            "issn": "00207519",
            "lastpage": "435",
            "pmid": "22502587",
            "pub_year": 2012,
            "title": "A novel recombinant Leishmania donovani p45, a partial coding region of methionine aminopeptidase, generates protective immunity by inducing a Th1 stimulatory response against experimental visceral leishmaniasis",
            "volume": "42"
        },
        "bib0280": {
            "authors": [
                {
                    "first": "P.",
                    "initial": "P.",
                    "last": "Probst"
                },
                {
                    "first": "E.",
                    "initial": "E.",
                    "last": "Stromberg"
                },
                {
                    "first": "H. W.",
                    "initial": "H.W.",
                    "last": "Ghalib"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Mozel"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Badaro"
                },
                {
                    "first": "S. G.",
                    "initial": "S.G.",
                    "last": "Reed"
                },
                {
                    "first": "J. R.",
                    "initial": "J.R.",
                    "last": "Webb"
                }
            ],
            "doi": "10.4049/jimmunol.166.1.498",
            "firstpage": "498",
            "issn": "00221767",
            "lastpage": "505",
            "pmid": "11123329",
            "pub_year": 2001,
            "title": "Identification and characterization of T cell-stimulating antigens from Leishmania by CD4 T cell expression cloning",
            "volume": "166"
        },
        "bib0285": {
            "authors": [
                {
                    "first": "Shyam",
                    "initial": "S.",
                    "last": "Sundar"
                },
                {
                    "first": "Bhawana",
                    "initial": "B.",
                    "last": "Singh"
                }
            ],
            "doi": "10.1586/14760584.2014.894467",
            "firstpage": "489",
            "issn": "14760584",
            "lastpage": "505",
            "pmid": "24606556",
            "pub_year": 2014,
            "title": "Identifying vaccine targets for anti-leishmanial vaccine development",
            "volume": "13"
        },
        "bib0290": {
            "authors": [
                {
                    "first": "Keerti",
                    "initial": "K.",
                    "last": "Jain"
                },
                {
                    "first": "N. K.",
                    "initial": "N.K.",
                    "last": "Jain"
                }
            ],
            "doi": "10.1016/j.jim.2015.03.017",
            "firstpage": "1",
            "issn": "00221759",
            "lastpage": "12",
            "pmid": "25858230",
            "pub_year": 2015,
            "title": "Vaccines for visceral leishmaniasis: A review",
            "volume": "422"
        },
        "bib0295": {
            "authors": [
                {
                    "first": "Rhea N.",
                    "initial": "R.N.",
                    "last": "Coler"
                },
                {
                    "first": "Malcolm S.",
                    "initial": "M.S.",
                    "last": "Duthie"
                },
                {
                    "first": "Kimberly A.",
                    "initial": "K.A.",
                    "last": "Hofmeyer"
                },
                {
                    "first": "Jeffery",
                    "initial": "J.",
                    "last": "Guderian"
                },
                {
                    "first": "Lakshmi",
                    "initial": "L.",
                    "last": "Jayashankar"
                },
                {
                    "first": "Julie",
                    "initial": "J.",
                    "last": "Vergara"
                },
                {
                    "first": "Tom",
                    "initial": "T.",
                    "last": "Rolf"
                },
                {
                    "first": "Ayesha",
                    "initial": "A.",
                    "last": "Misquith"
                },
                {
                    "first": "John D.",
                    "initial": "J.D.",
                    "last": "Laurance"
                },
                {
                    "first": "Vanitha S.",
                    "initial": "V.S.",
                    "last": "Raman"
                },
                {
                    "first": "H. Remy",
                    "initial": "H.R.",
                    "last": "Bailor"
                },
                {
                    "first": "Natasha Dubois",
                    "initial": "N.D.",
                    "last": "Cauwelaert"
                },
                {
                    "first": "Steven J.",
                    "initial": "S.J.",
                    "last": "Reed"
                },
                {
                    "first": "Aarthy",
                    "initial": "A.",
                    "last": "Vallur"
                },
                {
                    "first": "Michelle",
                    "initial": "M.",
                    "last": "Favila"
                },
                {
                    "first": "Mark T.",
                    "initial": "M.T.",
                    "last": "Orr"
                },
                {
                    "first": "Jill",
                    "initial": "J.",
                    "last": "Ashman"
                },
                {
                    "first": "Prakash",
                    "initial": "P.",
                    "last": "Ghosh"
                },
                {
                    "first": "Dinesh",
                    "initial": "D.",
                    "last": "Mondal"
                },
                {
                    "first": "Steven G.",
                    "initial": "S.G.",
                    "last": "Reed"
                }
            ],
            "doi": "10.1038/cti.2015.6",
            "issn": "20500068",
            "pub_year": 2015,
            "title": "From mouse to man: safety, immunogenicity and efficacy of a candidate leishmaniasis vaccine LEISH-F3+GLA-SE",
            "volume": "4"
        },
        "bib0300": {
            "authors": [
                {
                    "first": "Ines",
                    "initial": "I.",
                    "last": "Kevric"
                },
                {
                    "first": "Mark A.",
                    "initial": "M.A.",
                    "last": "Cappel"
                },
                {
                    "first": "James H.",
                    "initial": "J.H.",
                    "last": "Keeling"
                }
            ],
            "doi": "10.1016/j.det.2015.03.018",
            "firstpage": "579",
            "issn": "07338635",
            "lastpage": "593",
            "pmid": "26143433",
            "pub_year": 2015,
            "title": "New World and Old World Leishmania Infections: A Practical Review",
            "volume": "33"
        },
        "bib0305": {
            "authors": [
                {
                    "first": "Patricia A.",
                    "initial": "P.A.",
                    "last": "Darrah"
                },
                {
                    "first": "Dipti T.",
                    "initial": "D.T.",
                    "last": "Patel"
                },
                {
                    "first": "Paula M.",
                    "initial": "P.M.",
                    "last": "De Luca"
                },
                {
                    "first": "Ross W.B.",
                    "initial": "R.W.B.",
                    "last": "Lindsay"
                },
                {
                    "first": "Dylan F.",
                    "initial": "D.F.",
                    "last": "Davey"
                },
                {
                    "first": "Barbara J.",
                    "initial": "B.J.",
                    "last": "Flynn"
                },
                {
                    "first": "S\u00f8ren T.",
                    "initial": "S.T.",
                    "last": "Hoff"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Andersen"
                },
                {
                    "first": "Steven G.",
                    "initial": "S.G.",
                    "last": "Reed"
                },
                {
                    "first": "Sheldon L.",
                    "initial": "S.L.",
                    "last": "Morris"
                },
                {
                    "first": "Mario",
                    "initial": "M.",
                    "last": "Roederer"
                },
                {
                    "first": "Robert A.",
                    "initial": "R.A.",
                    "last": "Seder"
                }
            ],
            "doi": "10.1038/nm1592",
            "firstpage": "843",
            "issn": "10788956",
            "lastpage": "850",
            "pmid": "17558415",
            "pub_year": 2007,
            "title": "Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major",
            "volume": "13"
        }
    },
    "body_text": [
        {
            "endOffset": 58348,
            "parents": [],
            "secId": "sec0080",
            "sentence": "The p21 antigen does not have a human homolog.",
            "startOffset": 58302,
            "title": "Discussion"
        },
        {
            "endOffset": 60607,
            "parents": [],
            "secId": "sec0080",
            "sentence": "Following the verification that recombinant proteins retained protective efficacy when formulated with GLA-SE, we identified that each of the 8E, p21 and SMT proteins was still recognized by IFN\u03b3-producing T cells when presented within a mixture.",
            "startOffset": 60361,
            "title": "Discussion"
        },
        {
            "endOffset": 51472,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0045",
            "sentence": "For data generated using mouse samples, p-values were determined using one-way analysis of variance and Bonferroni's or Dunnett's multiple comparison test used to compare two groups, using GraphPad Prism 6 Prism software (GraphPad Software, Inc., La Jolla, CA, USA).",
            "startOffset": 51206,
            "title": "Statistical analyses"
        },
        {
            "endOffset": 57262,
            "parents": [],
            "secId": "sec0080",
            "sentence": "Vaccination has the potential to have a prolonged impact by protecting against infection/disease and reducing transmission by acting in infectious human reservoirs.",
            "startOffset": 57098,
            "title": "Discussion"
        },
        {
            "endOffset": 59675,
            "parents": [],
            "secId": "sec0080",
            "sentence": "The broader utility of including 8E is therefore less implied than p21, but evaluation of both in experimental models using these other Leishmania species appears merited.",
            "startOffset": 59504,
            "title": "Discussion"
        },
        {
            "endOffset": 49860,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0035",
            "sentence": "Cells were cultured at 2 \u00d7 105 cells per well in duplicate in a 96-well plate (Corning Incorporated, Corning, NY, USA) in RPMI-1640 supplemented with 5% heat-inactivated FCS and 50,000 Units penicillin/streptomycin (Invitrogen), in the presence of 10 \u03bcg/ml protein.",
            "startOffset": 49595,
            "title": "Determining antigen-specific cell responses"
        },
        {
            "endOffset": 52720,
            "parents": [
                {
                    "id": "sec0050",
                    "title": "Results"
                }
            ],
            "secId": "sec0060",
            "sentence": "The recombinant H2B, p45 and MDH were not preferentially bound by patient sera.",
            "startOffset": 52641,
            "title": "Antigen recognition by serum antibodies of VL patients"
        },
        {
            "endOffset": 48641,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0030",
            "sentence": "Blood was collected from five mice per group, serum prepared and antigen-specific antibody responses were analyzed by ELISA for total IgG, as well as IgG2 and IgG1 isotypes.",
            "startOffset": 48468,
            "title": "Analyses of mouse antibodies"
        },
        {
            "endOffset": 44914,
            "parents": [],
            "refoffsets": {
                "bib0255": {
                    "endOffset": 44913,
                    "startOffset": 44909
                }
            },
            "secId": "sec0005",
            "sentence": "We first verified that each recombinant protein retained protective efficacy when formulated with synthetic TLR4 ligand glucopyranosyl lipid adjuvant in stable emulsion (GLA-SE) [19].",
            "startOffset": 44731,
            "title": "Introduction"
        },
        {
            "endOffset": 56354,
            "parents": [
                {
                    "id": "sec0050",
                    "title": "Results"
                }
            ],
            "secId": "sec0070",
            "sentence": "The combination of these recombinant antigens therefore protects against experimental L. donovani infection.",
            "startOffset": 56246,
            "title": "Induction of antigen-specific responses and protection by simultaneous immunization with multiple proteins"
        },
        {
            "endOffset": 50482,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0040",
            "sentence": "One month after infection, livers were harvested, homogenized and parasite burden calculated by limiting dilution assay or by real-time PCR.",
            "startOffset": 50342,
            "title": "Infection and determination of parasite burden"
        },
        {
            "endOffset": 50893,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0040",
            "sentence": "L. donovani DNA was detected using primers for L42486 (forward, 5\u2032- GCGACGTCCGTGGAAAGAA-3\u2032; and reverse, 5\u2032- GGCGGGTACACATTAGCAGAA-3\u2032) with FAM reporter sequence (5\u2032- CAACGCGTATTCCC-3\u2032) that detects a 203-bp genomic repeat region specific to Leishmania species (NCBI Blastn).",
            "startOffset": 50618,
            "title": "Infection and determination of parasite burden"
        },
        {
            "endOffset": 49164,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0030",
            "sentence": "Plates were analyzed at 405 nm (ELX808, Bio-Tek Instruments Inc, Winooski, VT, USA).",
            "startOffset": 49080,
            "title": "Analyses of mouse antibodies"
        },
        {
            "endOffset": 56569,
            "parents": [
                {
                    "id": "sec0050",
                    "title": "Results"
                }
            ],
            "secId": "sec0075",
            "sentence": "The use of single protein within a defined subunit vaccine is a more tractable approach than developing scaled manufacturing and release assays of several proteins.",
            "startOffset": 56405,
            "title": "A novel fusion protein for protection against VL"
        },
        {
            "endOffset": 57941,
            "parents": [],
            "secId": "sec0080",
            "sentence": "This important validation step allowed the combination of the 8E, p21 and SMT antigens into a single fusion protein that would enhance vaccine uptake and be appropriate for industrial scale production and advancement.",
            "startOffset": 57724,
            "title": "Discussion"
        },
        {
            "endOffset": 42510,
            "parents": [],
            "refoffsets": {
                "bib0210": {
                    "endOffset": 42509,
                    "startOffset": 42502
                },
                "bib0215": {
                    "endOffset": 42509,
                    "startOffset": 42502
                },
                "bib0220": {
                    "endOffset": 42509,
                    "startOffset": 42502
                },
                "bib0225": {
                    "endOffset": 42509,
                    "startOffset": 42502
                }
            },
            "secId": "sec0005",
            "sentence": "The use of whole parasites and crude antigens with appropriate adjuvants has demonstrated the potential for vaccination to protect from leishmaniasis [10\u201313].",
            "startOffset": 42352,
            "title": "Introduction"
        },
        {
            "endOffset": 50341,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0040",
            "sentence": "Parasites had been routinely passed through Syrian golden hamsters to generate virulent amastigote and promastigote stocks in M199 medium.",
            "startOffset": 50203,
            "title": "Infection and determination of parasite burden"
        },
        {
            "endOffset": 51183,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0040",
            "sentence": "The number of parasite per \u03bcl of DNA was determined by extrapolating the Cp's of each sample against a standard curve generated with known quantities of parasites, then burdens expressed as parasites per organ.",
            "startOffset": 50973,
            "title": "Infection and determination of parasite burden"
        },
        {
            "endOffset": 46690,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0020",
            "sentence": "ELISA was conducted by coating high binding 384-well ELISA plates (Corning, MA, USA) overnight at 4 \u00b0C with 50 \u03bcl/well of recombinant protein at a concentration of 1 \u03bcg/ml diluted in carbonate buffer.",
            "startOffset": 46490,
            "title": "Antigen-specific antibody responses of VL patients"
        },
        {
            "endOffset": 47514,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0020",
            "sentence": "To reveal reactions, 100 \u03bcl of TMB SureBlue Peroxidase Substrate (Kirkegaard and Perry Laboratories, Gaithersburg, MD, USA) was added to each well for 15 min at room temperature, after which the reaction was stopped by adding 1 N H2SO4.",
            "startOffset": 47278,
            "title": "Antigen-specific antibody responses of VL patients"
        },
        {
            "endOffset": 46842,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0020",
            "sentence": "The next day, plates were washed with 0.1% Tween-20 in PBS and 200 \u03bcl of blocking buffer (PBS + 1% BSA) added to each well for 2 h at room temperature.",
            "startOffset": 46691,
            "title": "Antigen-specific antibody responses of VL patients"
        },
        {
            "endOffset": 55330,
            "parents": [
                {
                    "id": "sec0050",
                    "title": "Results"
                }
            ],
            "secId": "sec0070",
            "sentence": "When spleen cells from immunized mice were incubated with antigen, minimal quantities of IL-5, but large quantities of IFN\u03b3, were secreted (Fig. 3b).",
            "startOffset": 55181,
            "title": "Induction of antigen-specific responses and protection by simultaneous immunization with multiple proteins"
        },
        {
            "endOffset": 43107,
            "parents": [],
            "secId": "sec0005",
            "sentence": "A more feasible option for mass vaccination campaigns would appear to be the use of defined products, such as proteins produced by recombinant methods, used in conjunction with appropriate adjuvants.",
            "startOffset": 42908,
            "title": "Introduction"
        },
        {
            "endOffset": 49479,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0035",
            "sentence": "One month after the final immunization, spleens were removed from three mice per group and single cell suspensions prepared for each.",
            "startOffset": 49346,
            "title": "Determining antigen-specific cell responses"
        },
        {
            "endOffset": 47277,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0020",
            "sentence": "Plates were incubated for 30 min at room temperature, and then washed as previously described.",
            "startOffset": 47183,
            "title": "Antigen-specific antibody responses of VL patients"
        },
        {
            "endOffset": 41639,
            "parents": [],
            "secId": "sec0005",
            "sentence": "For L. donovani, some animals have been indicated to be infected but humans are believed to be the dominant source of transmission.",
            "startOffset": 41508,
            "title": "Introduction"
        },
        {
            "endOffset": 52640,
            "parents": [
                {
                    "id": "sec0050",
                    "title": "Results"
                }
            ],
            "secId": "sec0060",
            "sentence": "To determine if each protein was still recognized by antibodies within VL patient sera, we conducted antigen-specific antibody ELISA (Fig. 1).",
            "startOffset": 52498,
            "title": "Antigen recognition by serum antibodies of VL patients"
        },
        {
            "endOffset": 48782,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0030",
            "sentence": "Briefly, ELISA plates (Nunc, Rochester, NY, USA) were coated with 1 \u03bcg/ml antigen in 0.1 M bicarbonate buffer and blocked with 0.1% BSA-PBS.",
            "startOffset": 48642,
            "title": "Analyses of mouse antibodies"
        },
        {
            "endOffset": 47949,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0025",
            "sentence": "Female C57BL/6 mice (purchased from Charles River Laboratories, Wilmington, MA, USA) were maintained in specific pathogen-free conditions and in accordance with animal procedures approved by the IDRI institutional animal care and use committee.",
            "startOffset": 47705,
            "title": "Mice and immunizations"
        },
        {
            "endOffset": 46489,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0020",
            "sentence": "Subjects were defined according to parameters set by the Kala-Azar Elimination Program as follows: VL, a person with clinical symptoms of VL (fever for more than 2 weeks duration and splenomegaly) and a positive rK39 rapid diagnostic test result.",
            "startOffset": 46243,
            "title": "Antigen-specific antibody responses of VL patients"
        },
        {
            "endOffset": 54891,
            "parents": [
                {
                    "id": "sec0050",
                    "title": "Results"
                }
            ],
            "secId": "sec0070",
            "sentence": "\u03b1-tubulin was excluded at this juncture due to its high level of identity with human sequences.",
            "startOffset": 54796,
            "title": "Induction of antigen-specific responses and protection by simultaneous immunization with multiple proteins"
        },
        {
            "endOffset": 58971,
            "parents": [],
            "secId": "sec0080",
            "sentence": "It is possible that a vaccine targeting VL could also serendipitously protect against these other infections when antigens are preserved across the various species.",
            "startOffset": 58807,
            "title": "Discussion"
        },
        {
            "endOffset": 40501,
            "parents": [],
            "secId": "sec0005",
            "sentence": "The geographic distribution of particular Leishmania species affects the type, and severity, of disease that manifests in each area.",
            "startOffset": 40369,
            "title": "Introduction"
        },
        {
            "endOffset": 41108,
            "parents": [],
            "refoffsets": {
                "bib0170": {
                    "endOffset": 41107,
                    "startOffset": 41104
                }
            },
            "secId": "sec0005",
            "sentence": "L. infantum also infects canids and in addition to canine VL being a significant veterinary concern, infected dogs represent a major reservoir for potential transmission to humans in endemic regions [2].",
            "startOffset": 40905,
            "title": "Introduction"
        },
        {
            "endOffset": 57564,
            "parents": [],
            "refoffsets": {
                "bib0285": {
                    "endOffset": 57563,
                    "startOffset": 57556
                },
                "bib0290": {
                    "endOffset": 57563,
                    "startOffset": 57556
                }
            },
            "secId": "sec0080",
            "sentence": "Implementation of a defined subunit vaccine for VL based on recombinant antigen and appropriate formulation with adjuvant represents a feasible option, and based on assessments across a slew of vaccine platforms, many Leishmania genes/proteins have been proposed as vaccine candidate antigens [25,26].",
            "startOffset": 57263,
            "title": "Discussion"
        },
        {
            "endOffset": 40368,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Approximately, 12 million-diseased individuals are currently under management and an estimated 2 million additional new cases emerge each year.",
            "startOffset": 40225,
            "title": "Introduction"
        },
        {
            "endOffset": 43614,
            "parents": [],
            "refoffsets": {
                "bib0235": {
                    "endOffset": 43529,
                    "startOffset": 43525
                },
                "bib0240": {
                    "endOffset": 43550,
                    "startOffset": 43546
                },
                "bib0245": {
                    "endOffset": 43565,
                    "startOffset": 43561
                },
                "bib0250": {
                    "endOffset": 43613,
                    "startOffset": 43609
                }
            },
            "secId": "sec0005",
            "sentence": "Varying levels of protection in mouse models of L. donovani infection have been reported for several of these antigens, including KMP-11 (\u223c45% reduction in parasite burden) [15], rORFF (45\u221280%) [16], A2 (89%) [17], and hemoglobin receptor (100%; sterility) [18].",
            "startOffset": 43352,
            "title": "Introduction"
        },
        {
            "endOffset": 44272,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Incorporating multiple antigens has the potential to increase the number of individuals who can respond to the fusion protein, enhancing vaccine uptake and efficacy.",
            "startOffset": 44107,
            "title": "Introduction"
        },
        {
            "endOffset": 56690,
            "parents": [
                {
                    "id": "sec0050",
                    "title": "Results"
                }
            ],
            "secId": "sec0075",
            "sentence": "We therefore generated a single 79 kD chimeric fusion protein by the contiguous expression of the 8E, p21 and SMT genes.",
            "startOffset": 56570,
            "title": "A novel fusion protein for protection against VL"
        },
        {
            "endOffset": 52441,
            "parents": [
                {
                    "id": "sec0050",
                    "title": "Results"
                }
            ],
            "secId": "sec0055",
            "sentence": "There is a high degree of homology of these antigens across Leishmania species (Table 1), and suggesting that these recombinant forms would be recognized during infection with either of the causative agents of VL (L. donovani or L. infantum).",
            "startOffset": 52199,
            "title": "Characteristics of evaluated proteins"
        },
        {
            "endOffset": 58478,
            "parents": [],
            "refoffsets": {
                "bib0295": {
                    "endOffset": 58477,
                    "startOffset": 58473
                }
            },
            "secId": "sec0080",
            "sentence": "Of additional note, we recently demonstrated the safety of a vaccine containing the SMT antigen in a phase I clinical trial [27].",
            "startOffset": 58349,
            "title": "Discussion"
        },
        {
            "endOffset": 42257,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Thus, widespread vaccination programs are the most likely way in which VL elimination can be achieved.",
            "startOffset": 42155,
            "title": "Introduction"
        },
        {
            "endOffset": 60360,
            "parents": [],
            "refoffsets": {
                "bib0305": {
                    "endOffset": 60359,
                    "startOffset": 60355
                }
            },
            "secId": "sec0080",
            "sentence": "Indeed, the ability to produce large amounts of IFN\u03b3, typically from pluripotent antigen-specific Th1 cells, has been indicated as a reasonable predictor of protective immunity against intracellular pathogens [29].",
            "startOffset": 60146,
            "title": "Discussion"
        },
        {
            "endOffset": 51915,
            "parents": [
                {
                    "id": "sec0050",
                    "title": "Results"
                }
            ],
            "secId": "sec0055",
            "sentence": "Many antigens have been indicated to provide protection against experimental infection with at least one Leishmania species, but relatively little has been done to consolidate or demonstrate the robustness of the data that has been generated across different vaccine platforms (i.e. native, recombinant, DNA form of antigen).",
            "startOffset": 51590,
            "title": "Characteristics of evaluated proteins"
        },
        {
            "endOffset": 40046,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Leishmaniases cause human suffering on a global scale.",
            "startOffset": 39992,
            "title": "Introduction"
        },
        {
            "endOffset": 58599,
            "parents": [],
            "secId": "sec0080",
            "sentence": "These proteins are therefore anticipated to have no safety concerns if administered to volunteers during vaccine trials.",
            "startOffset": 58479,
            "title": "Discussion"
        },
        {
            "endOffset": 58301,
            "parents": [],
            "secId": "sec0080",
            "sentence": "In this regard, the 8E gene has 36% identity with a human homolog, although importantly it has no shared stretches that are greater than five amino acids and is therefore unlikely to contain any MHC I or II epitopes.",
            "startOffset": 58085,
            "title": "Discussion"
        },
        {
            "endOffset": 59778,
            "parents": [],
            "secId": "sec0080",
            "sentence": "Natural immunity against Leishmania parasites is mediated through a complex array of immune parameters.",
            "startOffset": 59675,
            "title": "Discussion"
        },
        {
            "endOffset": 61104,
            "parents": [],
            "secId": "sec0080",
            "sentence": "Further development of this chimeric fusion protein could yield a vaccine to combat VL and potentially other forms leishmaniasis.",
            "startOffset": 60975,
            "title": "Discussion"
        },
        {
            "endOffset": 48437,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0025",
            "sentence": "Mice were injected a total of three times at three weeks intervals.",
            "startOffset": 48370,
            "title": "Mice and immunizations"
        },
        {
            "endOffset": 41283,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Both strategies have limitations.",
            "startOffset": 41250,
            "title": "Introduction"
        },
        {
            "endOffset": 53656,
            "parents": [
                {
                    "id": "sec0050",
                    "title": "Results"
                }
            ],
            "secId": "sec0065",
            "sentence": "The generation of antigen-specific Th1 responses before infection was verified by measuring IFN\u03b3 and IL-5 after incubation of spleen cells from cohorts of immunized mice with their relevant immunizing antigen (data not shown).",
            "startOffset": 53430,
            "title": "Identification of antigens that can protect against L. donovani infection"
        },
        {
            "endOffset": 58806,
            "parents": [],
            "refoffsets": {
                "bib0300": {
                    "endOffset": 58805,
                    "startOffset": 58801
                }
            },
            "secId": "sec0080",
            "sentence": "While infection with L. donovani causes the majority of VL cases, L. infantum can also cause VL and infection with several other Leishmania species can cause less severe, but often disfiguring, disease [28].",
            "startOffset": 58599,
            "title": "Discussion"
        },
        {
            "endOffset": 50972,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0040",
            "sentence": "Mouse Gapdh FAM (Life Technologies) was used as an internal reference control.",
            "startOffset": 50894,
            "title": "Infection and determination of parasite burden"
        },
        {
            "endOffset": 44519,
            "parents": [],
            "secId": "sec0005",
            "sentence": "To consolidate the data generated by many laboratories and across many vaccine platforms, we expressed multiple Leishmania genes via recombinant expression in E. coli to permit their evaluation in a defined subunit antigen plus adjuvant platform.",
            "startOffset": 44273,
            "title": "Introduction"
        },
        {
            "endOffset": 56245,
            "parents": [
                {
                    "id": "sec0050",
                    "title": "Results"
                }
            ],
            "secId": "sec0070",
            "sentence": "In contrast, mice that were immunized with the mixture of the 8E, p21 and SMT proteins had significantly lower liver parasite burdens (Fig. 3c).",
            "startOffset": 56101,
            "title": "Induction of antigen-specific responses and protection by simultaneous immunization with multiple proteins"
        },
        {
            "endOffset": 54616,
            "parents": [
                {
                    "id": "sec0050",
                    "title": "Results"
                }
            ],
            "secId": "sec0070",
            "sentence": "As a development step before the generation of a single fusion protein that could serve as a vaccine candidate, mice were immunized with equimolar mixtures of selected proteins in GLA-SE.",
            "startOffset": 54429,
            "title": "Induction of antigen-specific responses and protection by simultaneous immunization with multiple proteins"
        },
        {
            "endOffset": 41507,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Transient eradication of the sandfly vectors provides only temporary abatement in the transmission cycle and the culling of diseased dogs has had little impact on the longer term VL situation in L. infantum-endemic regions.",
            "startOffset": 41284,
            "title": "Introduction"
        },
        {
            "endOffset": 45812,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0015",
            "sentence": "Affinity-purified protein fractions were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and quantified using the BCA protein assay (Pierce, Rockford, IL, USA).",
            "startOffset": 45619,
            "title": "Recombinant proteins"
        },
        {
            "endOffset": 60974,
            "parents": [],
            "secId": "sec0080",
            "sentence": "Our data identify a chimeric fusion protein incorporating the 8E, p21 and SMT antigens that, when formulated with GLA-SE, induces antigen-specific responses that protect against infection with L. donovani.",
            "startOffset": 60769,
            "title": "Discussion"
        },
        {
            "endOffset": 45618,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0015",
            "sentence": "The fusion proteins were constructed by aligning the individual gene sequences as a single product for cloning and recombinant expression in E. coli.",
            "startOffset": 45469,
            "title": "Recombinant proteins"
        },
        {
            "endOffset": 52198,
            "parents": [
                {
                    "id": "sec0050",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "bib0265": {
                    "endOffset": 52197,
                    "startOffset": 52190
                },
                "bib0270": {
                    "endOffset": 52197,
                    "startOffset": 52190
                },
                "bib0275": {
                    "endOffset": 52197,
                    "startOffset": 52190
                },
                "bib0280": {
                    "endOffset": 52197,
                    "startOffset": 52190
                }
            },
            "secId": "sec0055",
            "sentence": "Each selected gene/protein had previously been demonstrated to be either recognized by VL patients or to protect against at least one form of experimental leishmanaisis [21\u201324].",
            "startOffset": 52021,
            "title": "Characteristics of evaluated proteins"
        },
        {
            "endOffset": 47182,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0020",
            "sentence": "After incubation, plates were washed and 50 \u03bcl/well of peroxidase labeled-anti-human IgG (Life Technologies, CA, USA) in serum diluent was added.",
            "startOffset": 47037,
            "title": "Antigen-specific antibody responses of VL patients"
        },
        {
            "endOffset": 48112,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0025",
            "sentence": "Mice entered experiments at 6\u22128 weeks of age and were immunized by subcutaneous injection of recombinant protein formulated with adjuvant at the base of the tail.",
            "startOffset": 47950,
            "title": "Mice and immunizations"
        },
        {
            "endOffset": 43238,
            "parents": [],
            "secId": "sec0005",
            "sentence": "The recombinant nature of such vaccine antigens render them accessible to large scale, reproducible and cost-effective production.",
            "startOffset": 43108,
            "title": "Introduction"
        },
        {
            "endOffset": 59963,
            "parents": [],
            "secId": "sec0080",
            "sentence": "Central to these, however, are the presentation of antigens through the MHC I and MHC II pathways for the generation of parasite-specific T cells that can control Leishmania infection.",
            "startOffset": 59779,
            "title": "Discussion"
        },
        {
            "endOffset": 58084,
            "parents": [],
            "secId": "sec0080",
            "sentence": "Safety of any vaccine is an important consideration and this can be implied by selecting antigens that lack sequence identity with human genes.",
            "startOffset": 57941,
            "title": "Discussion"
        },
        {
            "endOffset": 49300,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0030",
            "sentence": "Endpoint titer was determined as the last optical density (OD) value greater than a threshold determined by sera from unimmunized mice.",
            "startOffset": 49165,
            "title": "Analyses of mouse antibodies"
        },
        {
            "endOffset": 53152,
            "parents": [
                {
                    "id": "sec0050",
                    "title": "Results"
                }
            ],
            "secId": "sec0060",
            "sentence": "These data also indicate, however, that responses are somewhat heterogeneous and several antigens may need to be included in order to broaden the potential for recognition in a vaccine.",
            "startOffset": 52967,
            "title": "Antigen recognition by serum antibodies of VL patients"
        },
        {
            "endOffset": 40224,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Due to their residency in endemic areas approximately 350 million people are at risk of infection with Leishmania parasites and therefore development of a form of leishmanaisis.",
            "startOffset": 40047,
            "title": "Introduction"
        },
        {
            "endOffset": 47680,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0020",
            "sentence": "Plates were read within 10 min of reaction stoppage at OD 450 nm, using 570 nm as the reference wavelength on a SpectraMax plate reader (Molecular Devices, CA, USA).",
            "startOffset": 47515,
            "title": "Antigen-specific antibody responses of VL patients"
        },
        {
            "endOffset": 40765,
            "parents": [],
            "secId": "sec0005",
            "sentence": "The largest VL burden is focused in the cross-border regions of Bangladesh, India and Nepal, where, as in east Africa, the disease is caused by infection with Leishmania donovani.",
            "startOffset": 40586,
            "title": "Introduction"
        },
        {
            "endOffset": 52020,
            "parents": [
                {
                    "id": "sec0050",
                    "title": "Results"
                }
            ],
            "secId": "sec0055",
            "sentence": "To allow the direct comparison of antigens, we expressed seven proteins by recombinant means in E. coli.",
            "startOffset": 51916,
            "title": "Characteristics of evaluated proteins"
        },
        {
            "endOffset": 56100,
            "parents": [
                {
                    "id": "sec0050",
                    "title": "Results"
                }
            ],
            "secId": "sec0070",
            "sentence": "These data also inherently indicate that the GLA-SE adjuvant does not confer protection, supporting observations from preliminary experiments that included animals immunized with adjuvant alone (data not shown).",
            "startOffset": 55889,
            "title": "Induction of antigen-specific responses and protection by simultaneous immunization with multiple proteins"
        },
        {
            "endOffset": 42352,
            "parents": [],
            "secId": "sec0005",
            "sentence": "An efficacious vaccine has, however, not yet been advanced to large-scale phase II/III trials.",
            "startOffset": 42258,
            "title": "Introduction"
        },
        {
            "endOffset": 45032,
            "parents": [],
            "secId": "sec0005",
            "sentence": "As a step toward a multivalent vaccine antigen we then assessed the interaction of selected proteins within mixtures.",
            "startOffset": 44915,
            "title": "Introduction"
        },
        {
            "endOffset": 46138,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0020",
            "sentence": "Sera were obtained from residents of a Leishmania-endemic area of Bangladesh (VL patients) or the United States (non-endemic normal).",
            "startOffset": 46005,
            "title": "Antigen-specific antibody responses of VL patients"
        },
        {
            "endOffset": 45336,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Our data identify a chimeric fusion protein that could potentially be used in targeted vaccination campaigns in L. donovani-endemic regions.",
            "startOffset": 45196,
            "title": "Introduction"
        },
        {
            "endOffset": 59356,
            "parents": [],
            "secId": "sec0080",
            "sentence": "Even when considering the most distant species that belong to the alternate subgenus Viannia (i.e. L. braziliensis) and cause cutaneous leishmaniasis in the Americas, the L. donovani p21 gene exhibits over 90% sequence conservation among Leishmania species.",
            "startOffset": 59099,
            "title": "Discussion"
        },
        {
            "endOffset": 53429,
            "parents": [
                {
                    "id": "sec0050",
                    "title": "Results"
                }
            ],
            "secId": "sec0065",
            "sentence": "To evaluate the potential of each protein to protect against VL, mice were immunized with recombinant protein formulated in GLA-SE then challenged by intravenous injection of L. donovani promastigotes.",
            "startOffset": 53228,
            "title": "Identification of antigens that can protect against L. donovani infection"
        },
        {
            "endOffset": 50202,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0040",
            "sentence": "Mice were infected by injection of 1 \u00d7 106 L. donovani (MHOM/SD/00/1S-2D) into the vein in the eye socket.",
            "startOffset": 50096,
            "title": "Infection and determination of parasite burden"
        },
        {
            "endOffset": 42907,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Furthermore, current regulations and release criteria appear prohibitive for the widespread administration of crude antigen vaccines.",
            "startOffset": 42774,
            "title": "Introduction"
        },
        {
            "endOffset": 59098,
            "parents": [],
            "secId": "sec0080",
            "sentence": "Therefore, when equivalence of antigens is observed in VL models the cross-species homology can be an appealing consideration.",
            "startOffset": 58972,
            "title": "Discussion"
        },
        {
            "endOffset": 43916,
            "parents": [],
            "secId": "sec0005",
            "sentence": "The criteria by which we chose to initially select potential vaccine antigens include sequence conservation among Leishmania species but a lack of sequence identity with human genes, as well as practical considerations such as the ability to express by recombinant methods and to purify at high levels.",
            "startOffset": 43614,
            "title": "Introduction"
        },
        {
            "endOffset": 53941,
            "parents": [
                {
                    "id": "sec0050",
                    "title": "Results"
                }
            ],
            "secId": "sec0065",
            "sentence": "With the exception of p45 immunized mice, protection, measured as a significant reduction of parasites relative to the levels observed in untreated control mice, was observed in all of the immunized groups (Fig. 2).",
            "startOffset": 53726,
            "title": "Identification of antigens that can protect against L. donovani infection"
        },
        {
            "endOffset": 48225,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0025",
            "sentence": "Vaccines were prepared to provide a total of 5 \u03bcg/dose protein and 5 \u03bcg/dose GLA-SE in a total volume of 0.1 ml.",
            "startOffset": 48113,
            "title": "Mice and immunizations"
        },
        {
            "endOffset": 55616,
            "parents": [
                {
                    "id": "sec0050",
                    "title": "Results"
                }
            ],
            "secId": "sec0070",
            "sentence": "These data indicate that each antigenic component is still recognized when presented within an equimolar mixture.",
            "startOffset": 55503,
            "title": "Induction of antigen-specific responses and protection by simultaneous immunization with multiple proteins"
        },
        {
            "endOffset": 42154,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Vaccination has the potential to provide not only long-term protection against infection/disease but could also impact infectious reservoirs to reduce transmission.",
            "startOffset": 41990,
            "title": "Introduction"
        },
        {
            "endOffset": 43351,
            "parents": [],
            "refoffsets": {
                "bib0230": {
                    "endOffset": 43350,
                    "startOffset": 43346
                }
            },
            "secId": "sec0005",
            "sentence": "Several antigens have been proposed and evaluated as vaccine candidates for various forms of leishmaniasis [14].",
            "startOffset": 43239,
            "title": "Introduction"
        },
        {
            "endOffset": 54320,
            "parents": [
                {
                    "id": "sec0050",
                    "title": "Results"
                }
            ],
            "secId": "sec0065",
            "sentence": "These data identify several proteins that, when expressed recombinantly in E. coli, can confer protection in a VL model.",
            "startOffset": 54200,
            "title": "Identification of antigens that can protect against L. donovani infection"
        },
        {
            "endOffset": 57723,
            "parents": [],
            "secId": "sec0080",
            "sentence": "Our data indicate that each of the seven targets evaluated in this study retained their protective potential when expressed as recombinant protein in E. coli.",
            "startOffset": 57565,
            "title": "Discussion"
        },
        {
            "endOffset": 54795,
            "parents": [
                {
                    "id": "sec0050",
                    "title": "Results"
                }
            ],
            "secId": "sec0070",
            "sentence": "We selected the 8E, p21 and SMT proteins for advancement based upon highly significant discrimination of VL patients from control and levels of protection in the infection model.",
            "startOffset": 54617,
            "title": "Induction of antigen-specific responses and protection by simultaneous immunization with multiple proteins"
        },
        {
            "endOffset": 45468,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "bib0260": {
                    "endOffset": 45467,
                    "startOffset": 45463
                }
            },
            "secId": "sec0015",
            "sentence": "Recombinant proteins were cloned and expressed in E. coli as previously described [20].",
            "startOffset": 45381,
            "title": "Recombinant proteins"
        },
        {
            "endOffset": 60145,
            "parents": [],
            "secId": "sec0080",
            "sentence": "The ideal vaccine against Leishmania species would induce strong, long-lasting Th1 cell responses that can promote parasite killing before immune subversion by the parasites occurs.",
            "startOffset": 59964,
            "title": "Discussion"
        },
        {
            "endOffset": 60769,
            "parents": [],
            "secId": "sec0080",
            "sentence": "By including multiple antigenic components in the vaccine antigen, the likelihood of recognition across the diversity of HLA in VL-affected regions is increased.",
            "startOffset": 60608,
            "title": "Discussion"
        },
        {
            "endOffset": 55502,
            "parents": [
                {
                    "id": "sec0050",
                    "title": "Results"
                }
            ],
            "secId": "sec0070",
            "sentence": "Importantly, mice that were immunized with mixtures of proteins responded with antigen-specific responses similar to those observed in mice immunized with single antigens.",
            "startOffset": 55331,
            "title": "Induction of antigen-specific responses and protection by simultaneous immunization with multiple proteins"
        },
        {
            "endOffset": 59503,
            "parents": [],
            "secId": "sec0080",
            "sentence": "The 8E gene is well conserved among Old World species of Leishmania but less conserved among species that cause cutaneous disease in the Americas.",
            "startOffset": 59357,
            "title": "Discussion"
        },
        {
            "endOffset": 54089,
            "parents": [
                {
                    "id": "sec0050",
                    "title": "Results"
                }
            ],
            "secId": "sec0065",
            "sentence": "Thus, immunization with recombinant proteins 8E, p21, \u03b1-tubulin, SMT (within the diffusion NS), even with H2B and MDH, protected against infection.",
            "startOffset": 53942,
            "title": "Identification of antigens that can protect against L. donovani infection"
        },
        {
            "endOffset": 55069,
            "parents": [
                {
                    "id": "sec0050",
                    "title": "Results"
                }
            ],
            "secId": "sec0070",
            "sentence": "To assess if each recombinant protein retained its immunogenicity when administered within a mixture, we evaluated the immune responses that were induced following immunization.",
            "startOffset": 54892,
            "title": "Induction of antigen-specific responses and protection by simultaneous immunization with multiple proteins"
        },
        {
            "endOffset": 47036,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0020",
            "sentence": "After blocking, plates are washed five times before serum samples diluted 1:400 dilution in 0.1% Tween-20 + 0.1% BSA in PBS was added at 50 \u03bcl/well and incubated for 30 min at room temperature.",
            "startOffset": 46843,
            "title": "Antigen-specific antibody responses of VL patients"
        },
        {
            "endOffset": 51542,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0045",
            "sentence": "Statistical significance was considered when the p-values were <0.05.",
            "startOffset": 51473,
            "title": "Statistical analyses"
        },
        {
            "endOffset": 53725,
            "parents": [
                {
                    "id": "sec0050",
                    "title": "Results"
                }
            ],
            "secId": "sec0065",
            "sentence": "Livers were harvested 1 month later and parasite burdens determined.",
            "startOffset": 53657,
            "title": "Identification of antigens that can protect against L. donovani infection"
        },
        {
            "endOffset": 57097,
            "parents": [],
            "secId": "sec0080",
            "sentence": "Despite their limitations, VL control strategies have centered predominantly on vector control or on improving drug treatment regimen.",
            "startOffset": 56963,
            "title": "Discussion"
        },
        {
            "endOffset": 52966,
            "parents": [
                {
                    "id": "sec0050",
                    "title": "Results"
                }
            ],
            "secId": "sec0060",
            "sentence": "In contrast, 8E, p21, \u03b1-tubulin and SMT antigens all provided statistically significant discrimination between patient and control sera, confirming that these recombinant proteins could still be recognized during the infectious process antigens.",
            "startOffset": 52721,
            "title": "Antigen recognition by serum antibodies of VL patients"
        },
        {
            "endOffset": 41249,
            "parents": [],
            "secId": "sec0005",
            "sentence": "To date, VL control strategies have predominantly centered on limiting the vectors and reservoirs or on improving the drug treatment regimen.",
            "startOffset": 41108,
            "title": "Introduction"
        },
        {
            "endOffset": 56952,
            "parents": [
                {
                    "id": "sec0050",
                    "title": "Results"
                }
            ],
            "secId": "sec0075",
            "sentence": "These data indicate that the fusion protein comprised of 8E, p21 and SMT has the potential to limit VL.",
            "startOffset": 56849,
            "title": "A novel fusion protein for protection against VL"
        },
        {
            "endOffset": 49594,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0035",
            "sentence": "Mononuclear cells were enumerated using a ViaCount assay with a PCA system (Guava Technologies, Hayward, CA, USA).",
            "startOffset": 49480,
            "title": "Determining antigen-specific cell responses"
        },
        {
            "endOffset": 45195,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Finally, we constructed a chimeric fusion protein incorporating the 8E, p21 and SMT proteins and evaluated if it could protect against infection with L. donovani.",
            "startOffset": 45033,
            "title": "Introduction"
        },
        {
            "endOffset": 55888,
            "parents": [
                {
                    "id": "sec0050",
                    "title": "Results"
                }
            ],
            "secId": "sec0070",
            "sentence": "When challenged by intravenous injection of L. donovani parasites, mice that were immunized with low levels of each individual protein formulated with GLA-SE exhibited no alteration in liver parasite burdens from those observed in mice that were not vaccinated (Fig. 3c).",
            "startOffset": 55617,
            "title": "Induction of antigen-specific responses and protection by simultaneous immunization with multiple proteins"
        },
        {
            "endOffset": 42773,
            "parents": [],
            "secId": "sec0005",
            "sentence": "The incredible difficulty in standardizing and optimally formulating crude preparations to selectively induce appropriate immune responses, however, are likely major factors in the inconsistent results that have been obtained in clinical trials of such vaccines.",
            "startOffset": 42511,
            "title": "Introduction"
        },
        {
            "endOffset": 45952,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0015",
            "sentence": "Endotoxin levels were measured by Limulus Amebocyte Lysate QCL-1000 assay (Lonza Inc., Basel, Switzerland) and were all <100 EU/mg protein.",
            "startOffset": 45813,
            "title": "Recombinant proteins"
        },
        {
            "endOffset": 49079,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0030",
            "sentence": "Then, in consecutive order and following washes in PBS/Tween, serially diluted serum samples, anti-mouse IgG-HRP, anti-mouse IgG1-HRP or anti-mouse IgG2a-HRP (Southern Biotech, Birmingham, AL, USA) and ABTS-H2O2 (Kirkegaard and Perry Laboratories, Gaithersburg, MD, USA) were added to the plates.",
            "startOffset": 48783,
            "title": "Analyses of mouse antibodies"
        },
        {
            "endOffset": 40904,
            "parents": [],
            "refoffsets": {
                "bib0165": {
                    "endOffset": 40903,
                    "startOffset": 40900
                }
            },
            "secId": "sec0005",
            "sentence": "VL cases in the Mediterranean, the Middle East, Latin America and some parts of Asia manifest from infection with Leishmania infantum [1].",
            "startOffset": 40766,
            "title": "Introduction"
        },
        {
            "endOffset": 46242,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0020",
            "sentence": "Written informed consent for study participation was obtained from each participant prior to screening.",
            "startOffset": 46139,
            "title": "Antigen-specific antibody responses of VL patients"
        },
        {
            "endOffset": 44106,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Extending upon early promise observed with single antigens, we then typically incorporate two to four components into single chimeric fusion molecules for further evaluation and production.",
            "startOffset": 43917,
            "title": "Introduction"
        },
        {
            "endOffset": 44730,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Given that VL is the most severe presentation of leishmaniasis, and that L. donovani infection causes the majority of VL cases, we decided to use a mouse model of L. donovani infection as the evaluation system.",
            "startOffset": 44520,
            "title": "Introduction"
        },
        {
            "endOffset": 50047,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0035",
            "sentence": "Culture supernatants were harvested after 4 days and cytokine (IL-5 and IFN\u03b3) content determined by ELISA, according to the manufacturer's instructions (eBioscience, San Diego, CA, USA).",
            "startOffset": 49861,
            "title": "Determining antigen-specific cell responses"
        },
        {
            "endOffset": 40585,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Visceral leishmaniasis (VL) is the most severe form and is fatal if left untreated.",
            "startOffset": 40502,
            "title": "Introduction"
        },
        {
            "endOffset": 50617,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0040",
            "sentence": "DNA was extracted from homogenate using QIAmp DNA mini kits (Qiagen) and quantified using Nanodrop UV\u2212vis spectrophotometer (ND-1000).",
            "startOffset": 50483,
            "title": "Infection and determination of parasite burden"
        },
        {
            "endOffset": 55180,
            "parents": [
                {
                    "id": "sec0050",
                    "title": "Results"
                }
            ],
            "secId": "sec0070",
            "sentence": "As expected, significant quantities of both antigen-specific IgG1 and IgG2a antibodies were induced (Fig. 3a).",
            "startOffset": 55070,
            "title": "Induction of antigen-specific responses and protection by simultaneous immunization with multiple proteins"
        },
        {
            "endOffset": 41989,
            "parents": [],
            "refoffsets": {
                "bib0175": {
                    "endOffset": 41988,
                    "startOffset": 41983
                },
                "bib0180": {
                    "endOffset": 41988,
                    "startOffset": 41983
                },
                "bib0185": {
                    "endOffset": 41988,
                    "startOffset": 41983
                },
                "bib0190": {
                    "endOffset": 41988,
                    "startOffset": 41983
                },
                "bib0195": {
                    "endOffset": 41988,
                    "startOffset": 41983
                },
                "bib0200": {
                    "endOffset": 41988,
                    "startOffset": 41983
                },
                "bib0205": {
                    "endOffset": 41988,
                    "startOffset": 41983
                }
            },
            "secId": "sec0005",
            "sentence": "It is now clear that a large number of individuals can be asymptomatically infected and, although improved drug regimens are becoming available for the treatment of VL, their toxicity or expense has meant that these can only be administered to disease individuals and chemoprophylaxis through mass drug administration does not appear feasible [3\u20139].",
            "startOffset": 41640,
            "title": "Introduction"
        },
        {
            "endOffset": 54199,
            "parents": [
                {
                    "id": "sec0050",
                    "title": "Results"
                }
            ],
            "secId": "sec0065",
            "sentence": "The levels of protection achieved were comparable to those attained by the injection of irradiated parasites.",
            "startOffset": 54090,
            "title": "Identification of antigens that can protect against L. donovani infection"
        },
        {
            "endOffset": 48369,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "sec0025",
            "sentence": "When multiple proteins were used simultaneously, they were mixed prior to use to provide molar equivalence of each within a total dose of 5 \u03bcg.",
            "startOffset": 48226,
            "title": "Mice and immunizations"
        },
        {
            "endOffset": 56848,
            "parents": [
                {
                    "id": "sec0050",
                    "title": "Results"
                }
            ],
            "secId": "sec0075",
            "sentence": "Mice immunized with this fusion protein formulated with GLA-SE exhibited lower parasite burdens than mice that were not immunized (Fig. 4; p-value = 0.0059).",
            "startOffset": 56691,
            "title": "A novel fusion protein for protection against VL"
        }
    ],
    "docId": "S0264410X16302328",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": "mduthie@idri.org",
                "first": "Malcolm S.",
                "initial": "M.S.",
                "last": "Duthie"
            },
            {
                "email": null,
                "first": "Michelle",
                "initial": "M.",
                "last": "Favila"
            },
            {
                "email": null,
                "first": "Kimberley A.",
                "initial": "K.A.",
                "last": "Hofmeyer"
            },
            {
                "email": null,
                "first": "Yeung L.",
                "initial": "Y.L.",
                "last": "Tutterrow"
            },
            {
                "email": null,
                "first": "Steven J.",
                "initial": "S.J.",
                "last": "Reed"
            },
            {
                "email": null,
                "first": "John D.",
                "initial": "J.D.",
                "last": "Laurance"
            },
            {
                "email": null,
                "first": "Alessandro",
                "initial": "A.",
                "last": "Picone"
            },
            {
                "email": null,
                "first": "Jeffrey",
                "initial": "J.",
                "last": "Guderian"
            },
            {
                "email": null,
                "first": "H. Remy",
                "initial": "H.R.",
                "last": "Bailor"
            },
            {
                "email": null,
                "first": "Aarthy C.",
                "initial": "A.C.",
                "last": "Vallur"
            },
            {
                "email": null,
                "first": "Hong",
                "initial": "H.",
                "last": "Liang"
            },
            {
                "email": null,
                "first": "Raodoh",
                "initial": "R.",
                "last": "Mohamath"
            },
            {
                "email": null,
                "first": "Julie",
                "initial": "J.",
                "last": "Vergara"
            },
            {
                "email": null,
                "first": "Randall F.",
                "initial": "R.F.",
                "last": "Howard"
            },
            {
                "email": null,
                "first": "Rhea N.",
                "initial": "R.N.",
                "last": "Coler"
            },
            {
                "email": null,
                "first": "Steven G.",
                "initial": "S.G.",
                "last": "Reed"
            }
        ],
        "doi": "10.1016/j.vaccine.2016.04.067",
        "firstpage": "2779",
        "issn": "0264410X",
        "keywords": [
            "Leishmania",
            "Protein",
            "Protozoa",
            "T cell",
            "Vaccine"
        ],
        "lastpage": "2786",
        "openaccess": "Full",
        "pub_year": 2016,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "Strategic evaluation of vaccine candidate antigens for the prevention of Visceral Leishmaniasis"
    }
}